Page last updated: 2024-09-04

dexmethylphenidate and methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate

dexmethylphenidate has been researched along with methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate in 1 studies

Compound Research Comparison

Studies
(dexmethylphenidate)
Trials
(dexmethylphenidate)
Recent Studies (post-2010)
(dexmethylphenidate)
Studies
(methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate)
Trials
(methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate)
Recent Studies (post-2010) (methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate)
1004601

Protein Interaction Comparison

ProteinTaxonomydexmethylphenidate (IC50)methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate (IC50)
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.1624
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)8.49
TransporterRattus norvegicus (Norway rat)0.252

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Subbaiah, MAM1

Reviews

1 review(s) available for dexmethylphenidate and methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate

ArticleYear
Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges.
    Journal of medicinal chemistry, 2018, 03-22, Volume: 61, Issue:6

    Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Drug Design; Humans; Selective Serotonin Reuptake Inhibitors

2018